SG Americas Securities, LLC

Broker-Dealer

Position in ABSI — Absci Corp

CIK 1313360 NEW YORK, NY

Position in ABSI

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,160,923

+$1,109,575 QoQ

Shares Held

100,166

+485.2% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 195 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. ABSI ranks #64 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,160,923	100,166	+485.2%	Shares	Sole	2026-08-07
2026-03-31	$51,348	17,116	-58.2%	Shares	Sole	2026-04-16
2025-12-31	$142,838	40,928	+87.0%	Shares	Sole	2026-01-09
2025-09-30	$66,521	21,882	+20.7%	Shares	Sole	2025-10-23
2025-06-30	$46,578	18,124	-47.1%	Shares	Sole	2025-08-08
2025-03-31	$86,032	34,276	-18.8%	Shares	Sole	2025-04-15
2024-12-31	$110,621	42,222	+278.6%	Shares	Sole	2025-01-17
2024-03-31	$63,343	11,152	-43.2%	Shares	Sole	2024-05-06
2023-03-31	$34,370	19,640	-13.9%	Shares	Sole	2023-04-28
2022-12-31	$47,890	22,805	+34.1%	Shares	Sole	2023-02-02
2022-09-30	$53,216	17,002	-11.0%	Shares	Sole	2022-10-31
2022-06-30	$63,441	19,109	—	Shares	Sole	2022-07-29
No filing history on record for this holder in this stock.